Versari, I.; Salucci, S.; Bavelloni, A.; Battistelli, M.; Traversari, M.; Wang, A.; Sampaolesi, M.; Faenza, I.
The Emerging Role and Clinical Significance of PI3K-Akt-mTOR in Rhabdomyosarcoma. Biomolecules 2025, 15, 334.
https://doi.org/10.3390/biom15030334
AMA Style
Versari I, Salucci S, Bavelloni A, Battistelli M, Traversari M, Wang A, Sampaolesi M, Faenza I.
The Emerging Role and Clinical Significance of PI3K-Akt-mTOR in Rhabdomyosarcoma. Biomolecules. 2025; 15(3):334.
https://doi.org/10.3390/biom15030334
Chicago/Turabian Style
Versari, Ilaria, Sara Salucci, Alberto Bavelloni, Michela Battistelli, Mirko Traversari, Ashley Wang, Maurilio Sampaolesi, and Irene Faenza.
2025. "The Emerging Role and Clinical Significance of PI3K-Akt-mTOR in Rhabdomyosarcoma" Biomolecules 15, no. 3: 334.
https://doi.org/10.3390/biom15030334
APA Style
Versari, I., Salucci, S., Bavelloni, A., Battistelli, M., Traversari, M., Wang, A., Sampaolesi, M., & Faenza, I.
(2025). The Emerging Role and Clinical Significance of PI3K-Akt-mTOR in Rhabdomyosarcoma. Biomolecules, 15(3), 334.
https://doi.org/10.3390/biom15030334
